American Century Companies Inc Puma Biotechnology, Inc. Transaction History
American Century Companies Inc
- $168 Billion
- Q4 2024
A detailed history of American Century Companies Inc transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 948,376 shares of PBYI stock, worth $3.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
948,376
Previous 874,543
8.44%
Holding current value
$3.4 Million
Previous $2.23 Million
29.69%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding PBYI
# of Institutions
110Shares Held
28.3MCall Options Held
27.9KPut Options Held
3.4K-
Vanguard Group Inc Valley Forge, PA3.64MShares$13 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.57MShares$12.8 Million0.0% of portfolio
-
Acorn Capital Advisors, LLC New York, NY2.45MShares$8.77 Million6.49% of portfolio
-
Acadian Asset Management LLC Boston, MA1.97MShares$7.06 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.89MShares$6.78 Million0.0% of portfolio
About PUMA BIOTECHNOLOGY, INC.
- Ticker PBYI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,556,000
- Market Cap $163M
- Description
- Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...